Seroprevalence of Antibodies to Hepatitis E Virus Among Pregnant Women

Mojgan Mamani ¹, Mehrangiz Zamani ², Seyyed Hamid Hashemi ¹, Fariba Keramat ¹ *

Cited by CrossRef: 6

1- Ahmad T, Hui J, Musa T, Behzadifar M, Baig M. Seroprevalence of hepatitis E virus infection in pregnant women: a systematic review and meta-analysis. Ann Saudi Med. 2020;40(2):136 [Crossref]

2- Farshadpour F, Taherkhani R, Ravanbod M, Eghbali S, Taherkhani S, Mahdavi E, Blackard J. Prevalence, risk factors and molecular evaluation of hepatitis E virus infection among pregnant women resident in the northern shores of Persian Gulf, Iran. PLoS ONE. 2018;13(1):e0191090 [Crossref]

3- Hadifar S, Sedighi M, Mostafaei S, Miri A, Amiri H, Abiri R, Babaei F, Kabir K, Moghoofei M. Prevalence of hepatitis E infection in the general population of Iran: a systematic review and meta-analysis. Future Virology. 2017;12(4):227 [Crossref]

4- Qashqari F. Seroprevalence of Hepatitis E Virus Infection in Middle Eastern Countries: A Systematic Review and Meta-Analysis. Medicina. 2022;58(7):905 [Crossref]

5- Azarkar Z, Sharifzadeh G, Ghanbarzadeh N. Seroprevalence and Risk Factors of Hepatitis E Among Women of Reproductive Age Residing in Birjand in 2016. Mod Care J. 2019;In Press(In Press) [Crossref]

6- Oluremi A, Opaleye O, Ogbolu D, Alli O, Adeola O, Alaka O, Ogunleke O, Ojo A, Bello M, Enitan S, Adediji I, Adelakun A, Suleiman I. High Viral Hepatitis Infection among Pregnant Women Attending Antenatal Clinic in Adeoyo Maternity Teaching Hospital Ibadan (AMTHI) Oyo State, Nigeria. Journal of Immunoassay and Immunochemistry. 2020;41(5):913 [Crossref]